21/#ICYMI #MondayNightIBD #ShortBowelSyndrome #MedTweetorial
💡 Focus: Pharmacologic Treatment

---
RT @MondayNightIBD
1/🏋️‍♀️Navigating tx for pts w #ShortBowelSyndrome is hard
@valcohranmd saves the day w #MedTweetorial 🧵
💪Get best practice ℹ4 adults & peds
w @DCharabaty & @BonumCe

🏆#CME ℹ️http://bit.ly/3Hgnpcf
Supported by an edu grant from @TakedaPharma

Where r u in your career?👇
https://twitter.com/MondayNightIBD/status/1617629375826120705

SBS in IBD — Current Activities

This CME-certified, Tweetorial will focus on pharmacologic treatment for patients with SBS.

Current Activities

20/#ICYMI #MondayNightIBD #ShortBowelSyndrome #MedTweetorial
💡 Focus: #ParenteralNutrition

---
RT @MondayNightIBD
1/📇Draw the rt cards #ParenteralNutrition #ShortBowelSyndrome w @valcohranmd @DCharabaty

#MNIBDTweetorial🧵
❤️PN Goals
♠️Dependence
♦️Complications
♣️Weaning, QoL +++

🏆#CME ℹ️http://bit.ly/3SZrpB4
Supported by an edu grant from @TakedaPharma

Where r u in your career?👇
https://twitter.com/MondayNightIBD/status/1579581166860275712

SBS in IBD — Current Activities

Current Activities

10/#ICYMI #MondayNightIBD #ShortBowelSyndrome #MedTweetorial
💡 Focus: #ParenteralNutrition

---
RT @MondayNightIBD
1/📇Draw the rt cards #ParenteralNutrition #ShortBowelSyndrome w @valcohranmd @DCharabaty

#MNIBDTweetorial🧵
❤️PN Goals
♠️Dependence
♦️Complications
♣️Weaning, QoL +++

🏆#CME ℹ️http://bit.ly/3SZrpB4
Supported by an edu grant from @TakedaPharma

Where r u in your career?👇
https://twitter.com/MondayNightIBD/status/1579581166860275712

SBS in IBD — Current Activities

Current Activities

9/#ICYMI #MondayNightIBD #ShortBowelSyndrome #MedTweetorial
💡 Focus: Pharmacologic Treatment

---
RT @MondayNightIBD
1/🏋️‍♀️Navigating tx for pts w #ShortBowelSyndrome is hard
@valcohranmd saves the day w #MedTweetorial 🧵
💪Get best practice ℹ4 adults & peds
w @DCharabaty & @BonumCe

🏆#CME ℹ️http://bit.ly/3Hgnpcf
Supported by an edu grant from @TakedaPharma

Where r u in your career?👇
https://twitter.com/MondayNightIBD/status/1617629375826120705

SBS in IBD — Current Activities

This CME-certified, Tweetorial will focus on pharmacologic treatment for patients with SBS.

Current Activities

Speaking of catching up on #TumorBoardTuesday’s 𝗙𝗥𝗘𝗘 CME, we’ll add a couple of awesome threads 🧵 from the last week you may have missed.

⏪ Rewind ⏪ to last week’s excellent deep dive 🤿 tweetorial from @DrMMurphy @MeganLeigh127 on #EndometrialCancer
---
RT @TumorBoardTues
1/#OncTwitter #TumorBoardTuesday #MedTweetorial 🧵

#EndometrialCancer AE deep dive🤿
🧪Trial results
🔬Tox for TKI-ICI
w @DrMMurphy @MeganLeigh127 & us!

🆓#CME @…
https://twitter.com/TumorBoardTues/status/1615518555717656576

#TumorBoardTuesday on Twitter

“1/#OncTwitter #TumorBoardTuesday #MedTweetorial 🧵 ✅#EndometrialCancer AE deep dive🤿 🧪Trial results 🔬Tox for TKI-ICI w @DrMMurphy @MeganLeigh127 & us! 🆓#CME @BonumCE🔗https://t.co/ioNvsko2Sc Supported by edu grants from Eisai & @Merck 🟢What's your specialty?”

Twitter
1/🏋️‍♀️Navigating tx for pts w #ShortBowelSyndrome is hard
@valcohranmd saves the day w #MedTweetorial 🧵
💪Get best practice ℹ4 adults & peds
w @DCharabaty & @BonumCe

🏆#CME ℹ️http://bit.ly/3Hgnpcf
Supported by an edu grant from @TakedaPharma

Where r u in your career?👇
SBS in IBD — Current Activities

This CME-certified, Tweetorial will focus on pharmacologic treatment for patients with SBS.

Current Activities

3/#TumorBoardTuesday #gyncsm #OncTwitter

🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
🤯Feeling left behind?

Don't fret, it's here📍

---
RT @BonumCe
1/ #OncTwitter #TumorBoardTuesday
#EndometrialCancer #MedTweetorial🧵
w @DrMMurphy @MeganLeigh127 @TumorBoardTues

🧬Tx response
🧪Trial results
🔬Tox for TKI-ICI

🆓#CME 🔗 http://bit.ly/3VBGJEJ
Supported by educational grants from Eisai & @Merck
https://twitter.com/BonumCe/status/1615519240542646275

EC Tweetorial — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit

Current Activities
2/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer #MedTweetorial

🆓 CME > full info➕ref list🗒️& program archive
👉http://bit.ly/3VBGJEJ

🔑#CME info👇
EC Tweetorial — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit

Current Activities

1/#OncTwitter #TumorBoardTuesday #MedTweetorial 🧵

#EndometrialCancer AE deep dive🤿
🧪Trial results
🔬Tox for TKI-ICI
w @DrMMurphy @MeganLeigh127 & us!

🆓#CME @BonumCe🔗http://bit.ly/3VBGJEJ
Supported by edu grants from Eisai & @Merck

🟢What's your specialty?

EC Tweetorial — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit

Current Activities

9/#TumorBoardTuesday #OncTwitter #NephTwitter #BonumCE

#ICYMI 🪡#RenalCell #MedTweetorial🧵
w @brian_rini @shilpaonc @katy_beckermann

🦺TKI/IO safety data
🥽Tox to look 4
⛑AE mgmt

---
RT @TumorBoardTues
1/ #OncTwitter #NephTwitter #TumorBoardTuesday
#RenalCell #MedTweetorial🧵
w @brian_rini @shilpaonc @katy_beckermann

🦺TKI/IO safety data
🥽Tox to look 4
⛑AE mgmt

🆓#CME @BonumCe🔗http://bit.ly/3VDaK81
Support by edu grants from Eisai…
https://twitter.com/TumorBoardTues/status/1602468719426342913

RCC Tweetorial — Current Activities

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Renal Cell Carcinoma (RCC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicit

Current Activities